All Posts Tagged With: "NABI"
(ALL) Company News for July 19, 2011 – Corporate Summary
• Shares of biotech company Bacterin International Holdings Inc (AMEX:BONE) gained 10.34% after the company posted initial second quarter earnings figures that came in above expectations• U.S. listed shares...
(NABI) Nabi Biopharmaceuticals’ Vaccine Program Advances
Nabi Biopharmaceuticals (NABI) has initiated the second phase III clinical trial for NicVAX, an investigational vaccine being developed for the treatment of nicotine addiction and preventing smoking relapse....
(NABI) Nabi Biopharmaceuticals’ Earnings Reports Bests Estimates
Nabi Biopharmaceuticals (NABI) reported fourth quarter fiscal 2009 (ended Dec 26, 2009) earnings of 2 cents per share (from continuing operations). This was well above the Zacks Consensus Estimate of a loss...
(GSK) Anti-Smoking Vaccine Offered by GlaxoSmithKline
GlaxoSmithKline (GSK) and Nabi Biopharmaceuticals (NABI) signed a licensing agreement for a nicotine conjugate vaccine (NicVAX) as well...
(GSK) Glaxo Expands Vaccine Portfolio – will buy Nabi’s PentaStaph vaccine
GlaxoSmithKline (GSK) recently entered an agreement with Nabi Biopharmaceuticals (NABI) to bring a new pipeline candidate into its vaccine portfolio. Glaxo will buy Nabi’s PentaStaph vaccine, which is being developed to fight hospital-acquired...